# SODIUM POLYSTYRENE SULFONATE
> **ANDA204071** · Abbreviated New Drug Application (Generic) · Sponsor: NUVO PHARMS INC · Approved 2014-11-28
## Drug
- **FDA Application Number:** ANDA204071
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM POLYSTYRENE SULFONATE
- **Generic name:** SODIUM POLYSTYRENE SULFONATE
- **Active ingredients:** SODIUM POLYSTYRENE SULFONATE
- **Dosage form:** POWDER
- **Route:** ORAL, RECTAL
- **Marketing status:** Prescription
- **Sponsor:** NUVO PHARMS INC
- **Manufacturer:** SUNRISE PHARMACEUTICAL, INC.
- **First approval:** 2014-11-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204071)
---
*MORVS · CC0 1.0*